Abstract:Background When employing the transcription-mediated amplification method for screening blood donors, there are some non-discriminatory reactive results which are screening assay reactive but HBV-DNA discriminatory assay negative. This raises concerns regarding the possibility of false positives among donors, which may lead to permanent deferral of blood donors and affect blood supply. This study aimed to elucidate the infection status of these non-discriminatory reactive blood donors and develop and validate a model to predict individualized hepatitis B status to establish an optimal screening strategy. Methods Supplementary tests were conducted on initial non-discriminating reactive donations to determine their HBV infection status, including repeat testing, viral load, serological marker detection, and follow-up. Primary clinical variables of the donors were recorded. Based on the Akaike information criterion, a stepwise forward algorithm was used to identify the predictive factors for information and construct a predictive model. The optimal screening strategy was determined through cost-effectiveness analysis. Results At the Blood Center of Zhejiang Province, 435 cases of initial non-discriminatory reactive donations were collected over two successive periods and sub-categorized through repeated testing into the following three groups: non-repeated positive group, non-discriminated positive group, and non-repeated HBV-DNA positive group. The HBV discriminatory rate increased after repeated testing (110/435, 25.29%). According to supplementary tests, the HBV-DNA positivity rate was 65.52% (285/435), and occult HBV infection was a significantly different among groups (χ 2 = 93.22, p < 0.01). The HBV serological markers and viral load in the non-repeated positive group differed from those in the other two groups, with a lower viral load and a higher proportion of false positives. The predictive model constructed using a stepwise forward algorithm exhibited high discrimination, good fit, high calibration, and effectiveness. A cost-effectiveness analysis indicated that utilizing repeated discriminatory testing and the predictive model is an extremely beneficial screening approach for non-discriminatory reactive blood donors. Conclusion Nearly two-third (65.52%) of the non-discriminatory reactive blood donors were HBV-DNA positive. Our innovative approach of constructing a predictive model as a supplementary screening strategy, combined with repeated discriminatory experiments, can effectively identify the infection status of non-discriminatory reactive blood donors, thereby increasing the safety of blood transfusions.

Modeling US blood donor deferrals under a policy of individual risk assessment for HIV risk sexual behavior

Implementation of sexual risk behavior donor screening in Canada

The impact of blood donation deferral strategies on the eligibility of men who have sex with men and other sexual risk behavior in Australia

End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral

Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re-emergence of syphilis and HIV pre-exposure prophylaxis use

Impact of recent criteria changes for the deferral criteria specific to men who have sex with men in France

Modelling the Need for New Blood Donors Following a Change in Deferral Period

Evaluation of a pre‐exposure prophylaxis (PrEP)/post‐exposure prophylaxis (PEP) deferral policy among blood donors

Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes

Analysis on Voluntary Blood Donation and Associated Factors in Men Who Have Sex with Men in 3 Cities in China

Questions on travel and sexual behaviours negatively impact ethnic minority donor recruitment: Effect of negative word‐of‐mouth and avoidance

Compliance of blood donors in Germany with non‐sexual deferral criteria

Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID‐19 pandemic

Stigmatizing deferrals disproportionally reduce donor return rates: Evidence from Brazil

Prevalence, incidence, and residual risk for human immunodeficiency virus among blood donors from 2003 to 2022 in Guangzhou, China

The prevalence of Human Immunodeficiency Virus infection among voluntary blood donors in mainland China: A systematic review and meta-analysis

Plasmid-mediated degradation of dibenzothiophene by Pseudomonas species

Acceptability of sexual history questions in a gender‐neutral risk assessment for blood donation

Establishing a screening strategy for non-discriminatory reactive blood donors by constructing a predictive model of hepatitis B virus infection status from a single blood center in China

Self-reported high-risk behavior among first-time and repeat replacement blood donors; a four-year retrospective study of patterns

How Many HIV Infections May Be Averted by Targeting Primary Infection in Men Who Have Sex With Men? Quantification of Changes in Transmission-Risk Behavior, Using an Individual-Based Model